Article

VEGF Trap has potential for treating a wide range of ocular neovascular diseases

Animal studies show efficacy of VEGF Trap where VEGF is over-expressed in photoreceptors

Related Videos
2 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Image credit: ©Ophthalmology Times
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
Wendy Lee, MD, talks about functional oculoplastics and aesthetics at EnVision Summit 2025
Related Content
Stuart Therapeutics completes Phase 3 trial of vezocolmitide for treatment of dry eye disease
January 22nd 2025

Stuart Therapeutics completes Phase 3 trial of vezocolmitide for treatment of dry eye disease

2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
December 13th 2024

California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco

BLINK2 study confirms lasting myopia control benefits in teenagers
January 22nd 2025

BLINK2 study confirms lasting myopia control benefits in teenagers

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

HelpMeSee announces new training partnerships, simulation training sites
January 21st 2025

HelpMeSee announces new training partnerships, simulation training sites

Glaukos announces several positive clinical updates for its iDose platform
January 20th 2025

Glaukos announces several positive clinical updates for its iDose platform

© 2025 MJH Life Sciences

All rights reserved.